 | • レポートコード：MRC2-11QY03907 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はナルコレプシー治療のグローバル市場について調査・分析したレポートです。種類別（オキシベートナトリウム、抗うつ薬、中枢神経刺激薬、その他）市場規模、用途別（脱力発作を伴う原発性ナルコレプシー、脱力発作を伴わない原発性ナルコレプシー、病状によるナルコレプシー、不特定ナルコレプシー）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ナルコレプシー治療の競争状況、市場シェア ・世界のナルコレプシー治療市場：種類別市場規模 2015年-2020年（オキシベートナトリウム、抗うつ薬、中枢神経刺激薬、その他） ・世界のナルコレプシー治療市場：種類別市場規模予測 2021年-2026年（オキシベートナトリウム、抗うつ薬、中枢神経刺激薬、その他） ・世界のナルコレプシー治療市場：用途別市場規模 2015年-2020年（脱力発作を伴う原発性ナルコレプシー、脱力発作を伴わない原発性ナルコレプシー、病状によるナルコレプシー、不特定ナルコレプシー） ・世界のナルコレプシー治療市場：用途別市場規模予測 2021年-2026年（脱力発作を伴う原発性ナルコレプシー、脱力発作を伴わない原発性ナルコレプシー、病状によるナルコレプシー、不特定ナルコレプシー） ・北米のナルコレプシー治療市場分析：米国、カナダ ・ヨーロッパのナルコレプシー治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのナルコレプシー治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のナルコレプシー治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのナルコレプシー治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Teva Pharmaceutical、Takeda、Jazz Pharmaceuticals、Arena Pharmaceuticals、Graymark Healthcare、Ligand Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Narcolepsy is a chronic neurological disorder that is associated with Excessive Daytime Sleepiness (EDS), hypnagogic hallucinations, cataplexy, sleep paralysis, and fragmented night sleep.
By therapeutic treatment, the global narcolepsy treatment market is segmented into central nervous system stimulants, sodium oxybate, and antidepressants.
Market Analysis and Insights: Global Narcolepsy Treatment Market
The global Narcolepsy Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Narcolepsy Treatment Scope and Market Size
Narcolepsy Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Narcolepsy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Teva Pharmaceutical
Takeda
Jazz Pharmaceuticals
Arena Pharmaceuticals
Graymark Healthcare
Ligand Pharmaceuticals
…
Market segment by Type, the product can be split into
Sodium Oxybate
Antidepressants
Central Nervous System Stimulants
Others
Market segment by Application, split into
Primary Narcolepsy with Cataplexy
Primary Narcolepsy without Cataplexy
Narcolepsy Due to Medical Conditions
Unspecified Narcolepsy
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Narcolepsy Treatment Revenue
1.4 Market by Type
1.4.1 Global Narcolepsy Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Sodium Oxybate
1.4.3 Antidepressants
1.4.4 Central Nervous System Stimulants
1.4.5 Others
1.5 Market by Application
1.5.1 Global Narcolepsy Treatment Market Share by Application: 2020 VS 2026
1.5.2 Primary Narcolepsy with Cataplexy
1.5.3 Primary Narcolepsy without Cataplexy
1.5.4 Narcolepsy Due to Medical Conditions
1.5.5 Unspecified Narcolepsy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Narcolepsy Treatment Market Perspective (2015-2026)
2.2 Global Narcolepsy Treatment Growth Trends by Regions
2.2.1 Narcolepsy Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Narcolepsy Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Narcolepsy Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Narcolepsy Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Narcolepsy Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Narcolepsy Treatment Players by Market Size
3.1.1 Global Top Narcolepsy Treatment Players by Revenue (2015-2020)
3.1.2 Global Narcolepsy Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Narcolepsy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Narcolepsy Treatment Market Concentration Ratio
3.2.1 Global Narcolepsy Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Narcolepsy Treatment Revenue in 2019
3.3 Narcolepsy Treatment Key Players Head office and Area Served
3.4 Key Players Narcolepsy Treatment Product Solution and Service
3.5 Date of Enter into Narcolepsy Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Narcolepsy Treatment Historic Market Size by Type (2015-2020)
4.2 Global Narcolepsy Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Narcolepsy Treatment Market Size by Application (2015-2020)
5.2 Global Narcolepsy Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Narcolepsy Treatment Market Size (2015-2020)
6.2 Narcolepsy Treatment Key Players in North America (2019-2020)
6.3 North America Narcolepsy Treatment Market Size by Type (2015-2020)
6.4 North America Narcolepsy Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Narcolepsy Treatment Market Size (2015-2020)
7.2 Narcolepsy Treatment Key Players in Europe (2019-2020)
7.3 Europe Narcolepsy Treatment Market Size by Type (2015-2020)
7.4 Europe Narcolepsy Treatment Market Size by Application (2015-2020)
8 China
8.1 China Narcolepsy Treatment Market Size (2015-2020)
8.2 Narcolepsy Treatment Key Players in China (2019-2020)
8.3 China Narcolepsy Treatment Market Size by Type (2015-2020)
8.4 China Narcolepsy Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Narcolepsy Treatment Market Size (2015-2020)
9.2 Narcolepsy Treatment Key Players in Japan (2019-2020)
9.3 Japan Narcolepsy Treatment Market Size by Type (2015-2020)
9.4 Japan Narcolepsy Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Narcolepsy Treatment Market Size (2015-2020)
10.2 Narcolepsy Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Narcolepsy Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Narcolepsy Treatment Market Size by Application (2015-2020)
11 India
11.1 India Narcolepsy Treatment Market Size (2015-2020)
11.2 Narcolepsy Treatment Key Players in India (2019-2020)
11.3 India Narcolepsy Treatment Market Size by Type (2015-2020)
11.4 India Narcolepsy Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Narcolepsy Treatment Market Size (2015-2020)
12.2 Narcolepsy Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Narcolepsy Treatment Market Size by Type (2015-2020)
12.4 Central & South America Narcolepsy Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Teva Pharmaceutical
13.1.1 Teva Pharmaceutical Company Details
13.1.2 Teva Pharmaceutical Business Overview
13.1.3 Teva Pharmaceutical Narcolepsy Treatment Introduction
13.1.4 Teva Pharmaceutical Revenue in Narcolepsy Treatment Business (2015-2020))
13.1.5 Teva Pharmaceutical Recent Development
13.2 Takeda
13.2.1 Takeda Company Details
13.2.2 Takeda Business Overview
13.2.3 Takeda Narcolepsy Treatment Introduction
13.2.4 Takeda Revenue in Narcolepsy Treatment Business (2015-2020)
13.2.5 Takeda Recent Development
13.3 Jazz Pharmaceuticals
13.3.1 Jazz Pharmaceuticals Company Details
13.3.2 Jazz Pharmaceuticals Business Overview
13.3.3 Jazz Pharmaceuticals Narcolepsy Treatment Introduction
13.3.4 Jazz Pharmaceuticals Revenue in Narcolepsy Treatment Business (2015-2020)
13.3.5 Jazz Pharmaceuticals Recent Development
13.4 Arena Pharmaceuticals
13.4.1 Arena Pharmaceuticals Company Details
13.4.2 Arena Pharmaceuticals Business Overview
13.4.3 Arena Pharmaceuticals Narcolepsy Treatment Introduction
13.4.4 Arena Pharmaceuticals Revenue in Narcolepsy Treatment Business (2015-2020)
13.4.5 Arena Pharmaceuticals Recent Development
13.5 Graymark Healthcare
13.5.1 Graymark Healthcare Company Details
13.5.2 Graymark Healthcare Business Overview
13.5.3 Graymark Healthcare Narcolepsy Treatment Introduction
13.5.4 Graymark Healthcare Revenue in Narcolepsy Treatment Business (2015-2020)
13.5.5 Graymark Healthcare Recent Development
13.6 Ligand Pharmaceuticals
13.6.1 Ligand Pharmaceuticals Company Details
13.6.2 Ligand Pharmaceuticals Business Overview
13.6.3 Ligand Pharmaceuticals Narcolepsy Treatment Introduction
13.6.4 Ligand Pharmaceuticals Revenue in Narcolepsy Treatment Business (2015-2020)
13.6.5 Ligand Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Narcolepsy Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Narcolepsy Treatment Revenue
Table 3. Ranking of Global Top Narcolepsy Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Narcolepsy Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Sodium Oxybate
Table 6. Key Players of Antidepressants
Table 7. Key Players of Central Nervous System Stimulants
Table 8. Key Players of Others
Table 9. Global Narcolepsy Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Narcolepsy Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Narcolepsy Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Narcolepsy Treatment Market Share by Regions (2015-2020)
Table 13. Global Narcolepsy Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Narcolepsy Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Narcolepsy Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Narcolepsy Treatment Players
Table 20. Global Narcolepsy Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Narcolepsy Treatment Market Share by Players (2015-2020)
Table 22. Global Top Narcolepsy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Narcolepsy Treatment as of 2019)
Table 23. Global Narcolepsy Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Narcolepsy Treatment Product Solution and Service
Table 26. Date of Enter into Narcolepsy Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Narcolepsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Narcolepsy Treatment Market Size Share by Type (2015-2020)
Table 30. Global Narcolepsy Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Narcolepsy Treatment Market Size Share by Application (2015-2020)
Table 32. Global Narcolepsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Narcolepsy Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Narcolepsy Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Narcolepsy Treatment Market Share (2019-2020)
Table 36. North America Narcolepsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Narcolepsy Treatment Market Share by Type (2015-2020)
Table 38. North America Narcolepsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Narcolepsy Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Narcolepsy Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Narcolepsy Treatment Market Share (2019-2020)
Table 42. Europe Narcolepsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Narcolepsy Treatment Market Share by Type (2015-2020)
Table 44. Europe Narcolepsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Narcolepsy Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Narcolepsy Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Narcolepsy Treatment Market Share (2019-2020)
Table 48. China Narcolepsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Narcolepsy Treatment Market Share by Type (2015-2020)
Table 50. China Narcolepsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Narcolepsy Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Narcolepsy Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Narcolepsy Treatment Market Share (2019-2020)
Table 54. Japan Narcolepsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Narcolepsy Treatment Market Share by Type (2015-2020)
Table 56. Japan Narcolepsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Narcolepsy Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Narcolepsy Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Narcolepsy Treatment Market Share (2019-2020)
Table 60. Southeast Asia Narcolepsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Narcolepsy Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Narcolepsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Narcolepsy Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Narcolepsy Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Narcolepsy Treatment Market Share (2019-2020)
Table 66. India Narcolepsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Narcolepsy Treatment Market Share by Type (2015-2020)
Table 68. India Narcolepsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Narcolepsy Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Narcolepsy Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Narcolepsy Treatment Market Share (2019-2020)
Table 72. Central & South America Narcolepsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Narcolepsy Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Narcolepsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Narcolepsy Treatment Market Share by Application (2015-2020)
Table 76. Teva Pharmaceutical Company Details
Table 77. Teva Pharmaceutical Business Overview
Table 78. Teva Pharmaceutical Product
Table 79. Teva Pharmaceutical Revenue in Narcolepsy Treatment Business (2015-2020) (Million US$)
Table 80. Teva Pharmaceutical Recent Development
Table 81. Takeda Company Details
Table 82. Takeda Business Overview
Table 83. Takeda Product
Table 84. Takeda Revenue in Narcolepsy Treatment Business (2015-2020) (Million US$)
Table 85. Takeda Recent Development
Table 86. Jazz Pharmaceuticals Company Details
Table 87. Jazz Pharmaceuticals Business Overview
Table 88. Jazz Pharmaceuticals Product
Table 89. Jazz Pharmaceuticals Revenue in Narcolepsy Treatment Business (2015-2020) (Million US$)
Table 90. Jazz Pharmaceuticals Recent Development
Table 91. Arena Pharmaceuticals Company Details
Table 92. Arena Pharmaceuticals Business Overview
Table 93. Arena Pharmaceuticals Product
Table 94. Arena Pharmaceuticals Revenue in Narcolepsy Treatment Business (2015-2020) (Million US$)
Table 95. Arena Pharmaceuticals Recent Development
Table 96. Graymark Healthcare Company Details
Table 97. Graymark Healthcare Business Overview
Table 98. Graymark Healthcare Product
Table 99. Graymark Healthcare Revenue in Narcolepsy Treatment Business (2015-2020) (Million US$)
Table 100. Graymark Healthcare Recent Development
Table 101. Ligand Pharmaceuticals Company Details
Table 102. Ligand Pharmaceuticals Business Overview
Table 103. Ligand Pharmaceuticals Product
Table 104. Ligand Pharmaceuticals Revenue in Narcolepsy Treatment Business (2015-2020) (Million US$)
Table 105. Ligand Pharmaceuticals Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Narcolepsy Treatment Market Share by Type: 2020 VS 2026
Figure 2. Sodium Oxybate Features
Figure 3. Antidepressants Features
Figure 4. Central Nervous System Stimulants Features
Figure 5. Others Features
Figure 6. Global Narcolepsy Treatment Market Share by Application: 2020 VS 2026
Figure 7. Primary Narcolepsy with Cataplexy Case Studies
Figure 8. Primary Narcolepsy without Cataplexy Case Studies
Figure 9. Narcolepsy Due to Medical Conditions Case Studies
Figure 10. Unspecified Narcolepsy Case Studies
Figure 11. Narcolepsy Treatment Report Years Considered
Figure 12. Global Narcolepsy Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Narcolepsy Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Narcolepsy Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Narcolepsy Treatment Market Share by Players in 2019
Figure 17. Global Top Narcolepsy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Narcolepsy Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Narcolepsy Treatment Revenue in 2019
Figure 19. North America Narcolepsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Narcolepsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Narcolepsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Narcolepsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Narcolepsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Narcolepsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Narcolepsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
ナルコレプシー治療薬の世界市場（～2026年） Narcolepsy is a chronic neurological disorder and results from the inability of one s body to regulate sleep-wake cycles. ... These sleep periods can range from seconds or minutes and in most extreme cases sometimes hours at one time. Market Analysis and Insights: Global Narcolepsy Therapeutics Mark…- ナルコレプシーの世界市場（～2026年） Narcolepsy is a neurological disorder that affects the control of sleep and wakefulness. People with narcolepsy experience excessive daytime sleepiness and intermittent, uncontrollable episodes of falling asleep during the daytime. These sudden sleep attacks may occur during any type of activity at …
- 慢性疲労症候群治療の世界市場（～2026年） Chronic fatigue syndrome is not a simple problem for any individual, it’s a complex disorder which is considered as thrilling fatigue, which cannot be able to explain by medical conditions. Chronic fatigue syndrome which can prime to deterioration of creatively suffering and harm of quality of life,…
- エネルギーベース非侵襲的医療美学治療システムの世界市場（～2026年） Energy-based non-invasive medical aesthetic treatment systems use sources of energy such as laser, ultrasound, and radio frequency (RF) to treat physical conditions. One of the major contributors to the growth of this market is growing awareness. Market Analysis and Insights: Global Energy-based Non…
- 胎児性アルコールスペクトラム障害（FASD）治療の世界市場（～2026年） Fetal alcohol spectrum disorder are the group of conditions occurring in new born with a wide range of disabilities. Fetal alcohol spectrum disorder treatment market is an evolving market owing to the gradual change in the lifestyle and increased alcohol consumption by pregnant women, eventually inc…